CR-HepB
Published by:
Ashermed Healthcare Communications
Description
中国乙肝随访与临床科研平台（CR-HepB）由中国国家卫生和计划生育委员会管理，中国肝炎防治基金会和中华医学会肝病学分会分别为项目主办方和执行方。CR-HepB是目前中国最大的慢性乙肝登记系统，系统利用互联网技术登记和管理慢性乙肝患者。
Screenshots
CR-HepB FAQ
-
Is CR-HepB free?
Yes, CR-HepB is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is CR-HepB legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does CR-HepB cost?
CR-HepB is free.
-
What is CR-HepB revenue?
To get estimated revenue of CR-HepB app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Egypt yet.
Ratings History
CR-HepB Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
CR-HepB Installs
Last 30 days
CR-HepB Revenue
Last 30 daysCR-HepB Revenue and Downloads
Gain valuable insights into CR-HepB performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
- Ashermed Healthcare Communications
- Languages
- English
- Recent release
- 1.0.9 (1 year ago )
- Released on
- Dec 15, 2016 (8 years ago )
- Also available in
- China , Russia , Romania , Lebanon , Malaysia , Nigeria , Norway , New Zealand , Peru , Philippines , Pakistan , Poland , Kuwait , Sweden , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , France , Brazil , Belarus , Chile , Czechia , Denmark , Algeria , Ecuador , Egypt , Spain , Kazakhstan , Hong Kong SAR China , Indonesia , Ireland , India , Italy , Japan , South Korea , Austria
- Last Updated
- 3 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.